Mesa Labs Corp (MLAB): רווח נקי למניה (EPS TTM)

Optimization through the delegation of assembly and logistics to external partners has strengthened the operational flexibility of Mesa Laboratories, Inc. (MLAB). The rolling 12-month earnings per share trend confirms the effectiveness of implementing autonomous validation systems and the stable operation of sterility indicator manufacturing plants. This metric is recorded at 1.16, demonstrating the business's actual financial resilience and its ability to generate profit.

Effective management of niche M&A deals and the protection of high margins at Mesa Laboratories, Inc. (MLAB) ensure a steady flow of capital into the business. This trend is reflected in the earnings per share calculations over the last four quarters, which offset the impact of securities issuance, allowing the company's trailing 12-month net income per share to differentiate real growth from temporary market fluctuations.